LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | QL-XII-47 | 0.04 | uM | LJP6 | 2 | O24 | 72 | hr | 1235 | 2757 | 4156 | 0.6634 | 0.5210 |
MCF7 | QL-XII-47 | 0.04 | uM | LJP6 | 3 | O24 | 72 | hr | 1235 | 2995 | 4156 | 0.7206 | 0.6025 |
MCF7 | Radicicol | 0.04 | uM | LJP5 | 1 | K12 | 72 | hr | 1235 | 2701 | 4156 | 0.6499 | 0.5018 |
MCF7 | Radicicol | 0.04 | uM | LJP5 | 2 | K12 | 72 | hr | 1235 | 3118 | 4156 | 0.7502 | 0.6446 |
MCF7 | Radicicol | 0.04 | uM | LJP5 | 3 | K12 | 72 | hr | 1235 | 2340 | 4156 | 0.5630 | 0.3782 |
MCF7 | Radicicol | 0.04 | uM | LJP6 | 1 | K12 | 72 | hr | 1235 | 2599 | 4156 | 0.6253 | 0.4669 |
MCF7 | Radicicol | 0.04 | uM | LJP6 | 2 | K12 | 72 | hr | 1235 | 2454 | 4156 | 0.5905 | 0.4172 |
MCF7 | Radicicol | 0.04 | uM | LJP6 | 3 | K12 | 72 | hr | 1235 | 2651 | 4156 | 0.6379 | 0.4847 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 1 | J06 | 72 | hr | 1235 | 4760 | 4156 | 1.1453 | 1.2067 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 2 | J06 | 72 | hr | 1235 | 4880 | 4156 | 1.1742 | 1.2478 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 3 | J06 | 72 | hr | 1235 | 4855 | 4156 | 1.1681 | 1.2393 |
MCF7 | Ruxolitinib | 0.04 | uM | LJP5 | 1 | O18 | 72 | hr | 1235 | 3867 | 4156 | 0.9304 | 0.9010 |
MCF7 | Ruxolitinib | 0.04 | uM | LJP5 | 2 | O18 | 72 | hr | 1235 | 3730 | 4156 | 0.8975 | 0.8541 |
MCF7 | Ruxolitinib | 0.04 | uM | LJP5 | 3 | O18 | 72 | hr | 1235 | 4077 | 4156 | 0.9810 | 0.9729 |
MCF7 | XL147 | 0.04 | uM | LJP5 | 1 | G12 | 72 | hr | 1235 | 4696 | 4156 | 1.1299 | 1.1848 |
MCF7 | XL147 | 0.04 | uM | LJP5 | 2 | G12 | 72 | hr | 1235 | 4683 | 4156 | 1.1268 | 1.1804 |
MCF7 | XL147 | 0.04 | uM | LJP5 | 3 | G12 | 72 | hr | 1235 | 4917 | 4156 | 1.1831 | 1.2605 |
MCF7 | Saracatinib | 0.04 | uM | LJP6 | 1 | D12 | 72 | hr | 1235 | 3805 | 4156 | 0.9155 | 0.8798 |
MCF7 | Saracatinib | 0.04 | uM | LJP6 | 2 | D12 | 72 | hr | 1235 | 4039 | 4156 | 0.9718 | 0.9599 |
MCF7 | Saracatinib | 0.04 | uM | LJP6 | 3 | D12 | 72 | hr | 1235 | 3458 | 4156 | 0.8320 | 0.7610 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 1235 | 4292 | 4156 | 1.0327 | 1.0465 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 1235 | 3482 | 4156 | 0.8378 | 0.7692 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 1235 | 4186 | 4156 | 1.0072 | 1.0102 |
MCF7 | Sirolimus | 0.04 | uM | LJP6 | 1 | L18 | 72 | hr | 1235 | 2445 | 4156 | 0.5883 | 0.4141 |
MCF7 | Sirolimus | 0.04 | uM | LJP6 | 2 | L18 | 72 | hr | 1235 | 2687 | 4156 | 0.6465 | 0.4970 |